Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
10 MG prednisone----[1] 44 💬
20 MG tropicamide----[1] 6 💬
30,25 MG RPC1063----[1] 96 💬
40,35% povidone-iodine solution lavage----[1] 46 💬
50,5 MG fingolimod----[1] 13 💬
60.005% lacripep----[1] 53 💬
70.01% lacripep----[1] 53 💬
80.02% FM, SH, 0.05% CSA----[1] 53 💬
90.02% FM, SH, AS----[1] 53 💬
100.02% FM, SH, tbcl----[1] 53 💬
110.03% using A foot pump----[1] 97 💬
120.04 MG LU AE04621----[1] 6 💬
130.05%cyclosporin EYE drop----[1] 38 💬
140.08 MG LU AE04621----[1] 6 💬
150.12% saline----[1] 299 💬
160.2 MG LU AE04621----[1] 6 💬
170.25 MG RPC103----[1] 97 💬
180.25 MG RPC1063----[3] 13, 96, 97 💬
190.25MG RPC103----[1] 97 💬
200.25MG RPC1063----[2] 13, 97 💬
210.3 MG tropicamide----[1] 6 💬
220.4 MG LU AE04621----[1] 6 💬
230.4ML prefilled syringes----[1] 107 💬
240.5 MG budesonide effervescent tablet FOR orodispersible USE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
250.5 MG RPC1063----[2] 13, 97 💬
260.5% marcaine----[1] 70 💬
270.5MG RPC1063----[1] 13 💬
280.6 MG LU AE04621----[1] 6 💬
290.7ML prefilled syringes----[1] 107 💬
300.8 MG LU AE04621----[1] 6 💬
310.9 % nacl----[1] 124 💬
320.9% chloride injection sodium----[1] 13 💬
330.9% isotonic saline (IS), 4ML----[1] 299 💬
340.9% physiological saline----[1] 266 💬
350.9% saline----[2] 6, 70 💬
360.9% sodium chloride----[5] 6, 14, 51, 53, 65 💬
370.9% sodium chloride injection----[2] 70, 168 💬
380.9% W/V isotonic sodium chloride solution----[1] 50 💬
390.9% W/V sodium chloride solution----[1] 299 💬
400.9ML sodium chloride----[1] 271 💬
410002-8971----[1] 70 💬
42009-0----[1] 6 💬
43009-1----[1] 6 💬
44009-2----[1] 6 💬
45009-3----[1] 6 💬
46009-4----[1] 6 💬
47009-5----[1] 6 💬
48009-A0----[1] 6 💬
49009-A1----[1] 6 💬
50009-A2----[1] 6 💬
51009-A3----[1] 6 💬
520109-0012A 100 MG/ML----[1] 46 💬
530109-0012A 25 MG/ML----[1] 46 💬
540109-0012A 50 MG/ML----[1] 46 💬
550114-0006B----[2] 46, 96 💬
561 - andrographis paniculata P/ST extract----[1] 13 💬
571 food elimination diet----[1] 98 💬
581 food elimination diet therapy----[1] 98 💬
591 infusion OF MSC----[1] 51 💬
601 MG budesonide effervescent tablet FOR orodispersible USE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
611 MG QD TO 15 MG QD PF-06649751[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[12] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
621 MG RPC1063----[2] 13, 97 💬
631 MG tropicamide----[1] 6 💬
641 MG/KG cnto 136----[1] 49 💬
651 ML 0.9 % nacl----[1] 46 💬
661 serving OF broccoli sprouts----[1] 97 💬
671% lignocaine----[1] 84 💬
681% steroid cream----[1] 13 💬
691) inosine 5'-monophosphate----[1] 17 💬
701,4-benzoxazepin-5(2H)-ONE, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] ----[1] 58 💬
711,4-benzoxazepin-5(2H)-ONE, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] ----[1] 58 💬
721,5 (butylimino)-1,5-dideoxy-D-glucitol----[1] 299 💬
731,5-anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3- (trifluoromethyl)-1,6-naphthyridin-6(5H)-YL]C----[1] 46 💬
741- deoxygalactonojirimycin----[1] 19 💬
751-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride----[1] 58 💬
761-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-D] pyrimidin-4-ONE----[1] 17 💬
771-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid----[1] 51 💬
781-20190----[1] 93 💬
791-22460----[1] 51 💬
801-cyclopropyl-6-fluoro-1,4-dihydro-4-OXO-7-[1-piperazinyl]-3-quinoline carboxylic acid----[1] 299 💬
811-deoxygalactonojirimycin hydrochloride[1] Migalastat[2] Migalastat hydrochloride ,
Migalastat 💬 		[1] GLA 💬 [5] Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬[1] 19 💬
821-deoxynojirimycin hydrochloride[1] Duvoglustat[2] Duvoglustat ,
Duvoglustat hydrochloride 💬 		[1] GAA 💬 [3] Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬[1] 256 💬
831-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-YL)OXY]-3-pyridinyl}-2-pyrrolidinone----[1] 13 💬
841.0 G vancomycin powder into THE wound----[1] 46 💬
851.0 MG LU AE04621----[1] 6 💬
861.0 MG rasagiline mesylate[1] Rasagiline[3] Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		[1] MAO 💬 [13] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬[1] 6 💬
871.0 MG RPC103----[1] 97 💬
881.0 MG RPC1063----[1] 97 💬
891.0 MIU IL-2 PER DAY----[1] 2 💬
901.0MG RPC1063----[1] 13 💬
911.2 MG LU AE04621----[1] 6 💬
921.2 MG ZGN-440 FOR injectable suspension----[1] 193 💬
931.5 X 10^6 UC-MSC + CM----[1] 90 💬
941.8 MG ZGN-440 FOR injectable suspension----[1] 193 💬
951.remicade[1] Infliximab[1] Infliximab 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 97 💬
9610 MG----[1] 96 💬
9710 MG natura-alpha capsule----[1] 97 💬
9810 MG/KG CM-101----[1] 51 💬
9910 MG/KG cnto 136----[1] 49 💬
10010% liquid formulation OF human immunoglobulin----[1] 14 💬
10110% nifedipine cream----[1] 50 💬
10210% nitroglycerine IN propylene glycol, USP[1] Nitroglycerin[1] Nitroglycerin 💬 --[1] 51 💬
10310-MG dose OF E5501 2G tablet----[1] 63 💬
10410-MG dose OF E5501 cyclodextrin oral solution----[1] 63 💬
10510-MG dose OF E5501 lipid-based oral----[1] 63 💬
10610-MG dose OF E5501-P21% powder----[1] 63 💬
10710-nitro-9(E)-octadec-9-enoic acid[1] CXA-10---[1] 86 💬
108100 MG----[4] 46, 96, 97, 271 💬
109100 MG AP1189----[2] 46, 222 💬
110100 MG ELX (VX-445) / 50 MG TEZ / 75 MG IVA FDC----[1] 299 💬
111100 MG ELX /50 MG TEZ /75 MG IVA FDC----[1] 299 💬
112100 MG ELX/50 MG TEZ /75 MG IVA FDC----[1] 299 💬
113100 MG ELX/50 MG TEZ/75 MG IVA fixed dose combination----[1] 299 💬
114100 MG LX3305 QD----[1] 46 💬
115100 MG TEZ/150 MG IVA FDC----[1] 299 💬
116100 MG VX-445 /50 MG TEZ/75 MG IVA FDC----[1] 299 💬
117100 MG VX-445/50 MG TEZ /75 MG IVA FDC----[1] 299 💬
118100 MG/M2 dose----[1] 299 💬
119100 µG brimonidine tartrate implant----[1] 90 💬
120100 µG KIO-301----[1] 90 💬
121100% OF individual calory requirement----[1] 2 💬
122100% pomegranate juice----[2] 96, 97 💬
123100-MG ELX (VX-445) / 50-MG TEZ / 75-MG IVA FDC----[1] 299 💬
124100-MG ELX (VX-455) / 50-MG TEZ / 75-MG IVA FDC----[1] 299 💬
125100-MG ELX / 50-MG TEZ / 75 -MG IVA FDC----[1] 299 💬
126100-MG VX-445 / 50-MG TEZ / 75- MG IVA FDC----[1] 299 💬
127100-MG VX-445 / 50-MG TEZ / 75-MG IVA FDC----[1] 299 💬
128100-MG VX-445 /50-MG TEZ/75-MG----[1] 299 💬
129100-MG VX-445/50-MG TEZ/75-MG IVA FDC----[1] 299 💬
1301000 IU D3----[1] 96 💬
13110000IU vitamin D----[1] 13 💬
1321000MG RTX group----[1] 46 💬
133100G ELX / 50MG TEZ / 75MG IVA----[1] 299 💬
134100MG ELX/50MG TEZ /75MG IVA----[1] 299 💬
135100MG FHND1002----[1] 2 💬
136100MG VX-445/50MG TEZ /75MG IVA FDC----[1] 299 💬
1371064NM laser----[1] 34 💬
1381064NM ND:YAG laser----[1] 34 💬
13911-ß-hydroxysteroid dehydrogenase type 1----[1] 75 💬
140111jc101----[1] 25 💬
141118-42-3----[2] 46, 49 💬
14211C-acetate[1] Acetic acid C-11---[3] 13, 86, 88 💬
14311C-BMS-986196----[1] 13 💬
14411C-csar----[2] 93, 94 💬
14511C-flumazenil----[1] 206 💬
14611C-MC1----[3] 6, 13, 46 💬
14711C-methionine PET/CT[1] Methionine C-11---[1] 75 💬
14811C-PBR28----[2] 6, 13 💬
14911C-PIB----[5] 5, 6, 7, 13, 17 💬
15011C-PS13----[2] 6, 13 💬
15111C-raclopride----[4] 5, 6, 7, 17 💬
15211C-UCB-J----[1] 6 💬
15311C-UCB-J PET-CT----[1] 8 💬
15412 lead electrocardiogram----[1] 19 💬
15512 MG/KG GSK2402968----[1] 113 💬
15612-lead ECG----[3] 58, 140, 144 💬
15712-month questionnaire----[1] 299 💬
158120 MG sodium nitrite inhalation solution----[1] 86 💬
159120% OF individual calory requirement----[1] 2 💬
160124I-AT03----[1] 28 💬
161124I-evuzamitide----[1] 70 💬
162124I-labeled monoclonal antibody MU 11-1f4----[1] 28 💬
163124I-P5+14 injection----[1] 28 💬
164129XE----[1] 299 💬
165129XE hyperpolarized----[1] 86 💬
166129XE small and large human lung coil----[1] 299 💬
16712S-IT----[1] 19 💬
16813 valent conjugated pneumococcal vaccine----[1] 265 💬
16913-15MG/KG/D ursodeoxycholic----[1] 93 💬
17013-PCV booster----[1] 13 💬
17113-valent pneumococcal conjugate vaccine----[2] 46, 53 💬
17213c6 leucine----[3] 5, 7, 127 💬
17313N-ammonia----[2] 6, 17 💬
17413nh3 PET/CT scan----[1] 84 💬
17515 MG QD DE-escalated TO 7 MG QD PF-06649751 IN parent study remain AT 7 MG QD[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[12] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
17615 MG sodium nitrite inhalation solution----[1] 86 💬
17715 or 45 MG----[1] 67 💬
17815-0 H20----[2] 6, 19 💬
17915-DAY taper prednisone----[1] 46 💬
18015-O labeled water----[1] 46 💬
181150 MG double-blinded secukinumab----[1] 271 💬
182150 MG FHND1002----[1] 2 💬
183150 MG GSK1265744B----[1] 265 💬
184150 MG LX3305 QD----[1] 46 💬
185150 MG OPEN-label secukinumab----[1] 271 💬
186150% OF their routine home dopaminergic medications dose right IN THE clinic----[1] 6 💬
187150-DAY taper prednisone----[1] 46 💬
188150-MG ivacaftor[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
1891500MG mesalazine pellets[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
190150MG CXA-10----[1] 86 💬
191150MG ivacaftor[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
19215n2-tofacitinib----[1] 97 💬
19315O H2O----[1] 6 💬
19416,5% cutaquig----[1] 65 💬
1951629063-78-0----[1] 19 💬
1961643368-58-4----[2] 53, 160 💬
19717,21-dihydroxypregna-1,4-diene-3,11,20-trione----[1] 41 💬
19817ß-hydroxy-11ß-(4-dimethylaminophenyl)17A-(PROP-1-ynyl)estra-4,9-DIEN-3-ONE----[1] 75 💬
19918 FDG----[1] 145 💬
20018-22MG/KG/D ursodeoxycholic----[1] 93 💬
20118-fdtbz----[1] 6 💬
20218F florbetaben----[1] 6 💬
20318F- dtbz----[1] 6 💬
20418F-AV-133[1] Florbenazine F-18---[1] 6 💬
20518F-AV-1451----[3] 5, 7, 127 💬
20618F-AV-45----[2] 6, 127 💬
20718F-dopa----[3] 6, 17, 75 💬
20818F-dopa PET----[1] 6 💬
20918F-dopamine----[2] 6, 17 💬
21018F-DPA-714 and 18F-FDG----[1] 13 💬
21118F-dtbz----[1] 6 💬
21218F-dtbz AV-133----[1] 6 💬
21318F-FDG[1] Fludeoxyglucose (18F)[1] Fludeoxyglucose F 18 💬 --[8] 5, 6, 7, 46, 84, 85, 127, 300 💬
21418F-FDG and 68GA-fapi PET/CT[1] Fludeoxyglucose (18F)[1] Fludeoxyglucose F 18 💬 --[1] 96 💬
21518F-FDG PET-MR[1] Fludeoxyglucose (18F)[1] Fludeoxyglucose F 18 💬 --[1] 8 💬
21618F-FDG PET/CT[1] Fludeoxyglucose (18F)[1] Fludeoxyglucose F 18 💬 --[1] 41 💬
21718F-FDG-PET/MRI[1] Fludeoxyglucose (18F)[1] Fludeoxyglucose F 18 💬 --[1] 84 💬
21818F-fgln PET imaging----[1] 86 💬
21918F-florbetaben----[1] 6 💬
22018F-fluoro-L-dopa----[1] 6 💬
22118F-fluorodeoxyglucose----[1] 84 💬
22218F-fluorodeoxyglucose (18F-FDG) PET/CT----[1] 84 💬
22318F-fspg[1] Florilglutamic acid F-18---[1] 84 💬
22418F-FTC-146----[1] 206 💬
22518F-GE-180[1] Flutriciclamide F-18---[1] 46 💬
22618F-GE180-PET/MRI----[1] 84 💬
22718F-OP-801----[3] 2, 6, 13 💬
22818F-PBR06----[1] 17 💬
22918F-PM-PBB3----[1] 13 💬
23018F-RO6958948----[3] 5, 7, 127 💬
23118F-SMBT-1----[1] 6 💬
23218FDG PET scan----[1] 41 💬
23318FDG PET/CT scan----[1] 84 💬
23419 NOR vitamin D----[1] 13 💬
2351[(6- allyl- 8ß- ERG----[1] 6 💬
2361[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----[1] 6 💬
2371H-pyrazol[1] Pyrazole---[2] 2, 75 💬
2381H/31P magnetic resonance spectroscopy----[1] 77 💬
2391MG budesonide effervescent tablet FOR orodispersible USE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
2401MG RPC1063----[1] 96 💬
2411MG/KG/HR TXA intravenous infusion till THE last suture----[1] 70 💬
2421ML prefilled syringes----[1] 107 💬
2432 - excipients----[1] 13 💬
2442 infusions OF MSC----[1] 51 💬
2452 MA transcranial direct current stimulation----[1] 13 💬
2462 MG perampanel----[1] 6 💬
2472 million hmsc/KG----[1] 46 💬
2482 X 10 MG natura-alpha capsules----[1] 97 💬
2492% chlorhexidine solution wipes[1] Chlorhexidine[4] Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬 		--[1] 299 💬
2502% lignocaine----[1] 84 💬
2512% sodium chondroitin sulfate----[1] 226 💬
2522',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid[1] Diflunisal[1] Diflunisal 💬 [1] PTGS2 💬 [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 28 💬
2532'-fucosyllactose----[2] 96, 97 💬
2542'-O-(2-methoxyethyl) phosphorothioate antisense oligonucleotide targeting CD49D RNA----[1] 113 💬
2552'-O-(2-methoxyethyl)-D-ribose antisense oligonucleotide targeting----[1] 131 💬
2562'-O-(2-methoxyethyl)-D-ribose antisense oligonucleotide targeting glial fibrillary acidic protein messenger ribonucleic acid----[1] 131 💬
2572(S)-(acetylamino)-4-methylpentanoic acid----[2] 19, 65 💬
2582,3-dihydroxybutanedioic acid----[1] 299 💬
2592,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-YL)-4,6-dimethylpyridine-1-oxide----[1] 6 💬
2602-(((2E)-3-(3-methoxy-4-(2-propyn-1-yloxy)phenyl)-1-OXO-2-propen-1-YL)amino)benzoic acid----[1] 51 💬
2612-(2-(2-amino-9H-purin-9-YL)ethyl)-1,3-propanediol diacetate ester[1] Famciclovir[1] Famciclovir 💬 --[1] 13 💬
2622-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylat----[1] 28 💬
2632-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate----[1] 28 💬
2642-(4-[5,6-diphenylpyrazin-2-YL)(isopropyl)amino]butoxy)-N-(methylsulfonyl)actamide----[1] 86 💬
2652-[(E)-[(E)-3-[1-(2-nitrophenyl)pyrrol-2-YL]PROP-2-enylidene]amino]guanidine----[1] 46 💬
2662-[4-[(2-amino-5-methyl-4-OXO-1,6,7,8-tetrahydropteridin-6-YL)methylam INO]benzoyl]amino----[1] 337 💬
2672-[[[(2R)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-OXO-2-pyrrolidinyl]carbonyl]amino]- N,N,6-trimethyl-4-pyridinecarboxamide,dihydrochloride----[2] 6, 162 💬
2682-amino-4-(methyl[11C]sulfanyl)butanoic acid----[1] 34 💬
2692-aminoethanethiol[1] Cysteamine[3] Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--[2] 19, 299 💬
2702-CDA[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
2712-CDA, 2-chloro-2'-deoxy-ß-D-adenosine[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
2722-CDA, 2-chloro-2?-deoxy-ß-D-adenosine[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
2732-CDA, 2-chloro-2’-deoxy-ß-D-adenosine[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
2742-chloro-2'-deoxyadenosine, 2CDA[1] Cladribine[1] Cladribine 💬 [1] RRM1 💬 [4] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬[1] 13 💬
2752-chloro-2?-deoxy-ß-D-adenosine----[1] 13 💬
2762-chloro-2’-deoxy-ß-D-adenosine----[1] 13 💬
2772-deoxy-2 [F-18] fluoro-2-D-glucose----[1] 49 💬
2782-hoba[1] 2-(aminomethyl)phenol---[2] 46, 86 💬
2792-hour holter monitor----[1] 19 💬
2802-hydroxypropyl-BETA-cyclodextrin[1] Hydroxypropyl betadex---[1] 19 💬
2812-isopropyl-3H-naphtho[2,1-D]imidazole-4,5-dione----[1] 21 💬
2822-{4-[(5,6-diphenylpyrazin-2-YL)(isopropyl)amino]butoxy}-N-(methylsulfonyl) acetamide----[1] 86 💬
2832-{7-[1,1-dimethyl-3-(4-sulfobutyl)-benz[E]indolin-2-ylidene]-1,3,5-heptatrienyl}-1,1-dimethyl-3-(sulfobutyl)-1H-benz[E]-indolium hydroxide,inner salt----[1] 46 💬
2842-{[(8Z)-13-[(methylcarbamoyl)formamido]- tridec-8-EN-1-YL]OXY}acetic acid----[1] 21 💬
2852-{[(8Z)-13-[(methylcarbamoyl)formamido]-tridec-8-EN-1-YL]OXY}acetic acid----[1] 21 💬
2862.0 MIU IL-2 PER DAY----[1] 2 💬
28720 MG----[1] 97 💬
28820 MG BID OF PF-02545920----[1] 8 💬
28920 MG GA----[1] 13 💬
29020 MG mitoq----[1] 13 💬
29120 MG/ML treprostinil[1] Treprostinil[3] Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
292200 MG BIA 6-512----[1] 6 💬
293200 MG LX3305 QD----[1] 46 💬
294200 MG/M2 dose----[1] 299 💬
295200 µG brimonidine tartrate implant----[1] 90 💬
296200-1600 µG OF MBX 2109 ONCE-weekly BY subcutaneous injection----[1] 235 💬
297200106 or EMD 28162----[1] 13 💬
298200MG cannabidiol BY capsules twice daily----[1] 46 💬
2992011-2012 seasonal FLU vaccine intramuscular----[2] 3, 113 💬
3002011-2012 seasonal FLU vaccine subcutaneous----[2] 3, 113 💬
3012019171-69-6----[1] 61 💬
302207-3120----[1] 6 💬
30320MG daily citalopram----[1] 8 💬
30420MG/0.5ML GA----[1] 13 💬
30520MG/0.5ML glatiramer acetate[1] Glatiramer[1] Glatiramer acetate 💬 [20] MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
30620MM sodium pyruvate nasal spray----[1] 85 💬
30723-PPV----[1] 13 💬
30823-valent pneumococcal polysaccharide vaccine----[3] 13, 46, 53 💬
30923-valent polysaccharide pneumococcal vaccine----[2] 96, 97 💬
31024 hour copper IN urine and liver function test----[1] 171 💬
31124-hour urine test----[1] 75 💬
312240MG amantadine HCL ER tablets----[1] 6 💬
31325 MG BIA9 1067----[1] 6 💬
31425 MG ongentys----[1] 6 💬
31525 MG ontamalimab----[2] 96, 97 💬
31625% MTD sodium nitrite inhalation solution----[1] 86 💬
31725(OH)D3----[1] 13 💬
318250 MG CK-2017357----[2] 2, 11 💬
319250 MG LX3305 BID----[1] 46 💬
320250 MG LX3305 QD----[1] 46 💬
321250MG FHND1002----[1] 2 💬
322250MG mesalazine pellets[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
32325OH-vitamin D[1] Cholecalciferol[1] Cholecalciferol 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[1] 13 💬
32426 common fabry mutation types IN taiwan----[1] 19 💬
3252622u90 duramycin[1] Lancovutide---[1] 299 💬
32629180.00.00, 34681.00.00, 34681.01.00, 34681.02.00----[1] 113 💬
3272b3-201----[1] 13 💬
3282L polyethylene glycol/ascorbic acid----[1] 97 💬
3292MG budesonide effervescent tablet FOR orodispersible USE[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
3302MG CS0159----[1] 93 💬
3312ML peripheral venous blood WAS collected TO detect genetic genes----[1] 97 💬
3322S,4R-(-)-ketoconazole----[1] 75 💬
3332S,4R-(-)-ketoconazole, levoketoconazole----[1] 75 💬
3343 bottles OF lactulose oral solution----[1] 97 💬
3353 MG----[1] 299 💬
3363 MG [14C]-A4250 capsule----[3] 93, 297, 338 💬
3373 MG melatonin----[1] 13 💬
3383 MG QD TO 15 MG QD PF-06649751[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[12] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
3393 MG/KG GSK2402968----[1] 113 💬
3403 mpdn pulse + PDN + CSA----[1] 50 💬
3413 mpdn pulse + PDN + MTX----[1] 50 💬
3423 servings OF broccoli sprouts----[1] 97 💬
3433 tesla MRI----[1] 127 💬
3443'mrna sequencing----[1] 41 💬
3453,4-diaminopyridine----[2] 12, 13 💬
3463,4-diaminopyridine phosphate[1] Phosphate ion---[1] 3 💬
3473- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate----[1] 6 💬
3483-(3,4-dihydroxyphenyl)-L-alanine----[1] 6 💬
3493-(3-(3,5-dimethyl-1H-pyrazol-4-YL)propoxy)-4-fluorobenzoic acid----[1] 28 💬
3503-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-YL]methyl}amino)pentanedioic acid----[1] 93 💬
3513-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt----[2] 51, 85 💬
35230 or 60 MG----[1] 67 💬
35330 or 90 MG----[1] 67 💬
35430 seconds SIT TO stand test----[1] 113 💬
35530-hour ambulatory sampling OF intestinal fluid----[1] 83 💬
356300 MG double-blinded secukinumab----[1] 271 💬
357300 MG LX3305 QD----[1] 46 💬
358300MG gemcabene----[1] 265 💬
35931-phosphorus RMN spectroscopy----[1] 8 💬
360320MG amantadine HCL ER tablets----[1] 6 💬
361331731-18-1----[5] 46, 96, 97, 107, 271 💬
36235MG----[2] 50, 107 💬
3633A,7A-dihydroxy-6A-ethyl-5ßcholan-24-OIC acid----[1] 93 💬
3643H-cholesterol bound TO albumin----[2] 259, 261 💬
3653HE human lung coil----[1] 299 💬
3663k3A-APC protein----[1] 2 💬
3673L-polyethylene glycol----[1] 97 💬
3683TC----[2] 265, 325 💬
3694 cholesten-3-ONE, oxime----[1] 2 💬
3704 food elimination diet----[1] 98 💬
3714 MA transcranial direct current stimulation----[1] 13 💬
3724 MG perampanel----[1] 6 💬
3734 MG/KG cnto 136----[1] 49 💬
3744 million hmsc/KG----[1] 46 💬
3754% chlorhexidine gluconate liquid skin cleanser----[1] 299 💬
3764'-chloro-2'-cyano-N-(trans-4-hydroxy-4-methylcyclohexyl)-biphenyl-4-sulphonamide----[1] 46 💬
3774'-IODO-4'-deoxydoxorubicin----[1] 28 💬
3784-(pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-ONE----[1] 58 💬
3794-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-ONE----[1] 58 💬
3804-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-benzamide, methane sulphonic acid salt. AB1010base----[1] 2 💬
3814-[5-(4-methylphenyl)-3-(trifluoromethyl)- 1H-pyrazol-1-YL] benzenesulfonamide----[1] 46 💬
3824-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL] benzenesulfonamide----[1] 46 💬
3834-aminopyridine[1] Dalfampridine[1] Dalfampridine 💬 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬 		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[2] 3, 13 💬
3844-aminosalicylic acid----[1] 96 💬
3854-aminosalicylic acid extended release granules----[1] 96 💬
3864-AP[1] Dalfampridine[1] Dalfampridine 💬 [4] KCNA4,
KCNC3,
KCND2,
KCND3 💬 		[4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 13 💬
3874-benzyl-2-naphtalen-1-YL-1,2,4-thiadiazolidine-3,5-dione----[1] 5 💬
3884-benzyl-2-naphthalen-1-YL-1,2,4- thiadiazolidine-3,5-dione----[1] 113 💬
3894-benzyl-2-naphthalen-1-YL-1,2,4-thiadiazolidine-3,5-dione----[1] 113 💬
3904-cholesten-3-ONE, oxime[1] Olesoxime[1] Olesoxime 💬 --[2] 2, 3 💬
3914-cholesten-3-ONE,oxime----[1] 3 💬
3924-methylpyrazole[1] Fomepizole[1] Fomepizole 💬 [3] ADH1_7,
ADH1_7,
ADH1_7 💬 		[8] Alcoholic liver disease, Drug metabolism - cytochrome P450, Fatty acid degradation, Glycolysis / Gluconeogenesis, Metabolism of xenobiotics by cytochrome P450, Pyruvate metabolism, Retinol metabolism, Tyrosine metabolism 💬[1] 301 💬
3934-PBA----[1] 231 💬
3944-{[(1R,2S,3S,5S,7S)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-B]pyridine-5-carboxamide monohydrobromide----[1] 46 💬
3954.2% nacl----[1] 340 💬
3964.2% nacl/inhalation solution----[2] 299, 340 💬
3974.5 MG naltrexone[1] Naltrexone[2] Naltrexone hydrochloride ,
Naltrexone 💬 		[3] OPRD1,
OPRK1,
OPRM1 💬 		[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13 💬
39840 MG----[1] 96 💬
39940 MG GA----[2] 2, 13 💬
40040 MG glatiramer acetate[1] Glatiramer[1] Glatiramer acetate 💬 [20] MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[2] 2, 13 💬
40140 MG glatiramer acetato[1] Glatiramer[1] Glatiramer acetate 💬 [20] MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		[32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬[1] 13 💬
40240 MG MSB11022----[5] 46, 96, 97, 107, 271 💬
40340 MG- soluzione iniettabile IN siringhe PRE-riempite- USO sottocutaneo- siringa preriempita (0,4ML)- 2 siringhe PRE-riempite + 2 tamponi imbevuti DI alcool----[1] 107 💬
404400 MG BIA 5-1058----[1] 86 💬
405400 MG LX3305 QD----[1] 46 💬
406400 µG brimonidine tartrate implant----[1] 90 💬
407400 µG OF MBX 2109 ONCE-weekly BY subcutaneous injection----[1] 235 💬
408400MG cannabidiol BY capsules twice daily----[1] 46 💬
40940MG OF mitoq----[1] 13 💬
41040MG triamcinolone injections IN THE bladder----[1] 226 💬
41144/154/85-C----[1] 50 💬
41244/196/81-C----[1] 50 💬
41345 GY external radiations----[1] 94 💬
41445 MG sodium nitrite inhalation solution----[1] 86 💬
4154au76----[1] 86 💬
4164D-125 IVT injection----[1] 90 💬
4174D-310[1] 4D-310---[1] 19 💬
4184D-710----[1] 299 💬
4195 ASA, enemas, suppositories, corticosteroids----[1] 97 💬
4205 MG melatonin----[1] 13 💬
4215 MG montelukast[1] Montelukast[2] Montelukast sodium ,
Montelukast 💬 		[1] CYSLTR1 💬 [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 98 💬
4225 MG prednisone----[1] 44 💬
4235% glucose water solution----[1] 2 💬
4245% lidocaine/5 MG/ML 0.02% estradiol compound cream----[1] 226 💬
4255% sildenafil cream----[1] 50 💬
4265,6,7,8-tetrahydrobiopterin[1] Sapropterin[2] Sapropterin dihydrochloride ,
Sapropterin 💬 		--[1] 240 💬
4275-(ethylsulfonyl)-2-(naphthalen-2-YL)benzo[D]oxazole----[1] 113 💬
4285-[4-[2-(5-(1-hydroxyethyl)-2- pyridinyl)ethoxy]benzyl]-2,4- thiazolidinedione hydrochloride----[1] 20 💬
4295-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride----[1] 20 💬
4305-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride----[1] 20 💬
4315-ALA[1] Aminolevulinic acid[2] Aminolevulinic acid hydrochloride ,
Aminolevulinic acid 💬 		--[2] 54, 180 💬
4325-amino salicylic acid----[1] 97 💬
4335-amino-2-hydroxybenzoic acid----[1] 97 💬
4345-aminolevulinic acid----[1] 96 💬
4355-aminosalicyclic acid----[1] 97 💬
4365-aminosalicyl acid----[1] 96 💬
4375-aminosalicylic acid[1] Mesalazine[1] Mesalamine 💬 --[2] 96, 97 💬
4385-aminosalicylic acid(5-ASA) and/or prednisone[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
4395-ASA[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
4405-ASA MMX[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
4415-chlor-6'-methyl- 3-[4-(methylsulfonyl)phenyl]- 2,3'-bipyridin----[2] 46, 271 💬
4425-chloro-1,2-dihydro-N-ethyl-4-hydroxy-1-methyl-2-OXO-N-phenyl-3-quinolinecarboxamide sodium----[1] 8 💬
4435-HTP----[2] 96, 97 💬
4445-hydroxytryptophan / vitamin B6----[1] 206 💬
4455-methyl-1-phenyl-2-1-(H)-pyridone----[1] 228 💬
4465-methyltetrahydrofolate and vitamin B12----[1] 299 💬
4475-mthf----[1] 337 💬
4485-probe cocktail----[1] 254 💬
4495-year follow-UP DPA-714-PET/MRI----[1] 6 💬
45050 MG----[1] 97 💬
45150 MG AP1189----[1] 46 💬
45250 MG BIA 9 1067----[1] 6 💬
45350 MG ELX/25 MG TEZ/37.5 MG IVA----[1] 299 💬
45450 MG ELX/25 MG TEZ/37.5 MG IVA fixed dose combination----[1] 299 💬
45550 MG etanercept[1] Etanercept[1] Etanercept 💬 [2] LTA,
TNF 💬 		[66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
45650 MG LX3305 QD----[1] 46 💬
45750 MG ongentys----[1] 6 💬
45850 patients will have A free choice between filgotinib and anti TNF[1] Filgotinib[2] Filgotinib ,
Filgotinib maleate 💬 		[4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[39] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
45950 µG KIO-301----[1] 90 💬
460500 0500 0----[1] 19 💬
461500 MG CK-2017357----[2] 2, 11 💬
462500 MG LX3305 QD----[1] 46 💬
4635000 IU D3----[1] 96 💬
4645000 IU OF cholecalciferol----[1] 299 💬
4655000IU vitamin D----[1] 13 💬
466500MG mesalazine pellets[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
467500MG RTX group----[1] 46 💬
46850MG FHND1002----[1] 2 💬
46952069.00.01----[1] 13 💬
470534-1508----[1] 85 💬
471549-0261/F02-01----[2] 96, 97 💬
472552-02----[2] 53, 299 💬
47356/104/75-C----[1] 50 💬
4745MG----[2] 50, 107 💬
4756 alpha-ethylchenodeoxycholic acid (6-edca), OCA, INT-747----[1] 93 💬
4766 food elimination diet therapy----[1] 98 💬
4776 mercaptopurine----[2] 96, 97 💬
4786 MG/KG GSK2402968----[1] 113 💬
4796 million hmsc/KG----[1] 46 💬
4806 months weight resistance and balance program----[1] 13 💬
4816% hypertonic saline (HS), 4ML----[1] 299 💬
4826-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine----[1] 38 💬
4836-(nitrooxy)hexyl(2Z)-4-(acetyloxy)-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoate----[1] 46 💬
4846-[(methyl-4-nitro-1H-imidazol-5-YL)thio]-1H-purine----[1] 96 💬
4856-[18F]fluorodopa----[1] 6 💬
4866-[18F]fluorodopamine----[1] 6 💬
4876-[2-(3,4-diethoxyphenyl)thiazol-4-YL] pyridine-2-carboxylic acid----[1] 97 💬
4886-ecdca[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
4896-ethynyl-1-(pentan-3-YL)-1H-imidazo[4,5-B]pyrazin-2(3H)-ONE----[1] 2 💬
4906-mercaptopurine[1] Mercaptopurine[2] Mercaptopurine ,
Mercaptopurine 💬 		[1] hprT 💬 [2] Drug metabolism - other enzymes, Purine metabolism 💬[3] 96, 97, 164 💬
4916-minute walk distance (6MWD) test----[2] 86, 88 💬
4926-minute walk distance (6MWD) test ON ambient AIR----[2] 86, 88 💬
4936-minute walk distance test with supplemental oxygen----[2] 86, 88 💬
4946-MP[1] Mercaptopurine[2] Mercaptopurine ,
Mercaptopurine 💬 		[1] hprT 💬 [2] Drug metabolism - other enzymes, Purine metabolism 💬[2] 96, 97 💬
49560% oxygen----[1] 85 💬
49660-minutes OF steady state exercise----[1] 265 💬
497600MG gemcabene----[1] 265 💬
498608 dose A----[1] 271 💬
499608 dose B----[1] 271 💬
500608 dose C----[1] 271 💬
50164CU-dotatate PET/CT scan[1] Copper oxodotreotide Cu-64---[1] 84 💬
50264cucl2----[1] 171 💬
50366215-101----[1] 86 💬
50468-GA HA-dotatate PET/CT----[1] 41 💬
50568GA-BMV101----[1] 85 💬
50668GA-bnota-PRGD2----[1] 46 💬
50768GA-DOTA-tate PET/MR and PET/CT imaging----[1] 238 💬
50868GA-DOTA-TOC PET/CT----[1] 84 💬
50968GA-dotanoc----[1] 84 💬
51068GA-dotatate[2] Dotatate,
Dotatate gallium Ga-68		[1] Edotreotide gallium Ga-68 💬 [1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 75 💬
51168GA-dotatate PET/CT[1] Dotatate gallium Ga-68[1] Edotreotide gallium Ga-68 💬 [1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 84, 238 💬
51268GA-dotatate PET/MRI[1] Dotatate gallium Ga-68[1] Edotreotide gallium Ga-68 💬 [1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 19 💬
51368GA-fapi----[3] 46, 97, 300 💬
51468GA-NEB----[3] 46, 89, 280 💬
51568GA-P16-093----[1] 53 💬
51668ganota-ANTI-MMR-VHH2----[1] 84 💬
5176?-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-747[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
5186A-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-747[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
5196A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
5206A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
5216A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
5226A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O[1] Obeticholic acid[1] Obeticholic acid 💬 [1] NR1H4 💬 [1] Bile secretion 💬[1] 93 💬
5236Aß - apomorphine-10,11-diol hydrochloride hemihydrate[1] Apomorphine[2] Apomorphine hydrochloride ,
Apomorphine 💬 		[2] DRD1,
DRD2 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6 💬
5246R-BH4[1] Sapropterin[2] Sapropterin dihydrochloride ,
Sapropterin 💬 		--[2] 86, 124 💬
5257 MG QD TO 15 MG QD PF-06649751[1] Tavapadon[1] Tavapadon 💬 [2] DRD1,
DRD5 💬 		[12] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬[1] 6 💬
5267% hypertonic saline VIA nebulization----[1] 299 💬
5277% nacl----[1] 299 💬
5287% saline----[1] 299 💬
5297-BETA-hydroxyepiandrosterone[1] 7-beta-Hydroxyepiandrosterone---[1] 6 💬
5307-valent pneumococcal conjugate vaccine----[1] 46 💬
53170930.00.00----[1] 46 💬
53275 MG ontamalimab----[2] 96, 97 💬
53375-MG ivacaftor[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
534750MG mesalazine pellets[1] Mesalazine[1] Mesalamine 💬 --[1] 97 💬
535755NM alexandrite laser----[1] 34 💬
53675MG CXA-10----[1] 86 💬
53776517-01-4----[1] 77 💬
5388-ohdg[1] 8-hydroxy-2'-deoxyguanosine---[1] 6 💬
53980 MG DR-6MP----[1] 96 💬
540800 MG ibuprofen/26.6 MG famotidine----[1] 107 💬
54180MG ELX / 40MG TEZ / 60MG IVA----[1] 299 💬
54281409-90-7----[1] 77 💬
54381MG aspirin----[1] 49 💬
54489 ZR-DF-crefmirlimab----[2] 13, 25 💬
54589ZR-bevacizumab[2] Bevacizumab,
Bevacizumab zirconium Zr-89		[1] Bevacizumab 💬 [1] VEGFA 💬 [23] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[1] 34 💬
54689ZR-DFO-AP-101----[1] 2 💬
54789ZR-DFO-CZP----[1] 46 💬
54889ZR-SBC-103[1] Lesinidase alfa[1] Lesinidase alfa 💬 [1] NAGLU 💬 [2] Glycosaminoglycan degradation, Lysosome 💬[1] 19 💬
5499 MG/KG GSK2402968----[1] 113 💬
5509-chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-B] quinoxaline----[1] 46 💬
5519-CIS, 12-CIS-11,11-D2-linoleic acid ethyl ester----[2] 2, 5 💬
55290 MG hydrocortisone acetate suppository with sephure suppository applicator[3] Acetate,
Hydrocortisone,
Hydrocortisone acetate		[2] Hydrocortisone ,
Hydrocortisone acetate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
55390 MG idrocortisone acetato IN supposta CON applicatore PER supposte sephure----[1] 97 💬
55490 MG sodium nitrite inhalation solution----[1] 86 💬
555900MG teta 4HCL once daily formulation[1] Triethylenetetramine[2] Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--[1] 171 💬
5569060X----[2] 13, 149 💬
55795% pure ecgc capsules 200MG----[1] 13 💬
5589715X----[1] 90 💬
5599741X----[1] 90 💬
5609742X----[1] 90 💬
56198% dehydrated alcohol----[1] 298 💬
56298-92-0----[1] 107 💬
56399M technetium infliximab----[1] 84 💬
56499MTC-3prgd2----[1] 46 💬
56599MTC-infliximab----[1] 84 💬
56699MTC-rhannexin V-128----[2] 46, 271 💬
56799MTC-S-hynic certolizumab pegol[1] Certolizumab pegol[1] Certolizumab pegol 💬 [1] TNF 💬 [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[2] 46, 96 💬
5689mw3811 injection----[1] 85 💬